Development of genetically engineered CD4 + and CD8 + T cells expressing TCRs specific for a M. tuberculosis 38-kDa antigen

Journal of Molecular Medicine

Volumn 89, Issue 9, 2011, Pages 903-913

  Luo, Wei ^a   Zhang, Xiao Bing ^b   Huang, Yong Ta ^a   Hao, Pei Pei ^a   Jiang, Zhen Min ^a   Wen, Qian ^a   Zhou, Ming Qian ^a   Jin, Qi ^b   Ma, Li ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF PATHOGEN BIOLOGY   (China)

Author keywords

38 kDa; Adoptive immunotherapy; CDR3 spectratype; Mycobacterium tuberculosis; TCR

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; RETROVIRUS VECTOR; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SUBSTITUTION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SURFACE; CYTOLYSIS; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MYCOBACTERIUM TUBERCULOSIS; NORMAL HUMAN; T LYMPHOCYTE RECEPTOR GENE; TH1 CELL; TUBERCULOSIS;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIGENS, BACTERIAL; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; GENETIC VECTORS; HEK293 CELLS; HUMANS; LIPOPROTEINS; MICE; NIH 3T3 CELLS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TH1 CELLS;

EID: 80052462121     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-011-0760-4     Document Type: Article

References (33)

1. JL Flynn J Chan 2001 Immunology of tuberculosis Annu Rev Immunol 19 93 129 11244032 10.1146/annurev.immunol.19.1.93 1:CAS:528:DC%2BD3MXivFKgtbo%3D [PubMed: 11244032] (Pubitemid 32368031)
2. S Stenger DA Hanson R Teitelbaum P Dewan KR Niazi CJ Froelich T Ganz S Thoma-Uszynski A Melián C Bogdan, et al. 1998 An antimicrobial activity of cytolytic T cells mediated by granulysin Science 282 121 125 9756476 10.1126/science.282.5386.121 1:CAS:528:DyaK1cXmsFOisL8%3D [PubMed: 9756476] (Pubitemid 28471143)
3. C Berger CJ Turtle MC Jensen SR Riddell 2009 Adoptive transfer of virus-specific and tumor-specific T cell immunity Curr Opin Immunol 21 224 232 19304470 10.1016/j.coi.2009.02.010 1:CAS:528:DC%2BD1MXlsVCgtb4%3D [PubMed: 19304470]
4. JS Woodworth Y Wu SM Behar 2008 Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo J Immunol 181 8595 8603 19050279 1:CAS:528:DC%2BD1cXhsVCktrzK [PubMed: 19050279]
5. D Duffy A Dawoodji EM Agger P Andersen J Westermann EB Bell 2009 Immunological memory transferred with CD4 T cells specific for tuberculosis antigens Ag85B-TB10.4: persisting antigen enhances protection PLoS ONE 4 e8272 20011592 10.1371/journal.pone.0008272 [PubMed: 20011592]
6. K Kitsukawa F Higa Y Takushi H Miyagi T Kakazu H Fukuhara H Nakamura H Kaneshima Y Irabu K Shimoji, et al. 1991 Adoptive immunotherapy for pulmonary tuberculosis caused by multi-resistant bacteria using autologous peripheral blood leucocytes sensitized with killed Mycobacterium tuberculosis bacteria Kekkaku 66 563 575 1942728 1:STN:280:DyaK38%2Fks12msw%3D%3D [PubMed: 1942728]
7. K Kikkawa 1992 Adoptive immunotherapy of refractory pulmonary tuberculosis using sensitized autologous lymphocytes Kekkaku 67 684 686 1453574 1:STN:280:DyaK3s%2FosFyrtg%3D%3D [PubMed: 1453574]
8. L Gattinoni DJ Powell Jr SA Rosenberg NP Restifo 2006 Adoptive immunotherapy for cancer: building on success Nat Rev Immunol 6 383 393 16622476 10.1038/nri1842 1:CAS:528:DC%2BD28XjslOgsrw%3D [PubMed: 16622476]
9. S Thomas HJ Stauss EC Morris 2010 Molecular immunology lessons from therapeutic T-cell receptor gene transfer Immunology 129 170 177 20561357 10.1111/j.1365-2567.2009.03227.x 1:CAS:528:DC%2BC3cXht1ert70%3D [PubMed: 20561357]
10. RA Morgan ME Dudley JR Wunderlich MS Hughes JC Yang RM Sherry RE Royal SL Topalian US Kammula NP Restifo, et al. 2006 Cancer regression in patients after transfer of genetically engineered lymphocytes Science 314 126 129 16946036 10.1126/science.1129003 1:CAS:528:DC%2BD28XhtVCiurrK [PubMed: 16946036] (Pubitemid 44547756)
11. HW Kessels MC Wolkers MD van den Boom MA van der Valk TN Schumacher 2001 Immunotherapy through TCR gene transfer Nat Immunol 2 957 961 11577349 10.1038/ni1001-957 1:CAS:528:DC%2BD3MXnsVCis7w%3D [PubMed: 11577349] (Pubitemid 32976169)
12. M Leisegang B Engels P Meyerhuber E Kieback D Sommermeyer SA Xue S Reuss H Stauss W Uckert 2008 Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette J Mol Med 86 573 583 18335188 10.1007/s00109-008-0317-3 1:CAS:528:DC%2BD1cXlt1agu7k%3D [PubMed: 18335188]
13. KB Scholten D Kramer EW Kueter M Graf T Schoedl CJ Meijer MW Schreurs E Hooijberg 2006 Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells Clin Immunol 119 135 145 16458072 10.1016/j.clim.2005.12.009 1:CAS:528:DC%2BD28XjsFOgs78%3D [PubMed: 16458072]
14. RH Voss RA Willemsen J Kuball M Grabowski R Engel RS Intan P Guillaume P Romero C Huber M Theobald 2008 Molecular design of the Calphabeta interface favors specific pairing of introduced TCRalphabeta in human T cells J Immunol 180 391 401 18097040 1:CAS:528:DC%2BD2sXhsVGjur7L [PubMed: 18097040]
15. Z Sebestyén E Schooten T Sals I Zaldivar E San José B Alarcón S Bobisse A Rosato J Szöllosi JW Gratama, et al. 2008 Human TCR that incorporate CD3zeta induce highly preferred pairing between TCRalpha and beta chains following gene transfer J Immunol 180 7736 7746 18490778 [PubMed: 18490778]
16. CJ Cohen YF Li M El-Gamil PF Robbins SA Rosenberg RA Morgan 2007 Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond Cancer Res 67 3898 3903 17440104 10.1158/0008-5472.CAN-06- 3986 1:CAS:528:DC%2BD2sXkt1Kiurs%3D [PubMed: 17440104] (Pubitemid 46762178)
17. J Kuball ML Dossett M Wolfl WY Ho RH Voss C Fowler PD Greenberg 2007 Facilitating matched pairing and expression of TCR chains introduced into human T cells Blood 109 2331 2338 17082316 10.1182/blood-2006-05-023069 1:CAS:528:DC%2BD2sXnslygsrk%3D [PubMed: 17082316] (Pubitemid 46425872)
18. CJ Cohen Y Zhao Z Zheng SA Rosenberg RA Morgan 2006 Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability Cancer Res 66 8878 8886 16951205 10.1158/0008-5472.CAN-06-1450 1:CAS:528:DC%2BD28XovF2ht7c%3D [PubMed: 16951205] (Pubitemid 44449206)
19. G Bialer M Horovitz-Fried S Ya'acobi RA Morgan CJ Cohen 2010 Selected murine residues endow human TCR with enhanced tumor recognition J Immunol 184 6232 6241 20427762 10.4049/jimmunol.0902047 1:CAS:528:DC%2BC3cXmtFyqtrc%3D [PubMed: 20427762]
20. D Sommermeyer W Uckert 2010 Minimal amino acid exchange in human TCR constant regions fosters improved function of TCR gene-modified T cells J Immunol 184 6223 6231 20483785 10.4049/jimmunol.0902055 1:CAS:528: DC%2BC3cXmtFyqtrY%3D PubMed: 20483785]
21. J Zhou D Weng F Zhou K Pan H Song Q Wang H Wang H Wang Y Li L Huang, et al. 2009 Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti-tumor activity: in vitro results and clinical responses Cancer Immunol Immunother 58 1587 1597 19221746 10.1007/s00262-009- 0668-9 1:CAS:528:DC%2BD1MXptVentrw%3D [PubMed: 19221746]
22. W Luo L Ma Q Wen N Wang MQ Zhou XN Wang 2008 Analysis of the interindividual conservation of T cell receptor alpha- and beta-chain variable regions gene in the peripheral blood of patients with systemic lupus erythematosus Clin Exp Immunol 154 316 324 18811695 10.1111/j.1365-2249.2008. 03770.x 1:CAS:528:DC%2BD1MXjs1Krtw%3D%3D [PubMed: 18811695]
23. RB Batchu AM Moreno S Szmania SK Gupta F Zhan N Rosen M Kozlowski T Spencer GC Spagnoli J Shaughnessy, et al. 2003 High-level expression of cancer/testis antigen NY-ESO-1 and human granulocyte-macrophage colony-stimulating factor in dendritic cells with a bicistronic retroviral vector Hum Gene Ther 14 1333 1345 14503968 10.1089/104303403322319417 1:CAS:528:DC%2BD3sXntFGiu7s%3D [PubMed: 14503968] (Pubitemid 37174757)
24. D Kalamasz SA Long R Taniguchi JH Buckner RJ Berenson M Bonyhadi 2004 Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and anti-CD28 antibodies J Immunother 27 405 418 15314550 10.1097/00002371-200409000-00010 1:CAS:528:DC%2BD2cXmsl2gsr8%3D [PubMed: 15314550] (Pubitemid 39121930)
25. SM Smith MR Klein AS Malin J Sillah KP McAdam HM Dockrell 2002 Decreased IFN- gamma and increased IL-4 production by human CD8(+) T cells in response to Mycobacterium tuberculosis in tuberculosis patients Tuberc Edinb 82 7 13 10.1054/tube.2001.0317 1:STN:280:DC%2BD387ot1eguw%3D%3D [PubMed: 11914057] (Pubitemid 34454544)
26. Z Popmihajlov FR Santori D Gebreselassie AD Sandler S Vukmanovic 2010 Effective adoptive therapy of tap-deficient lymphoma using diverse high avidity alloreactive T cells Cancer Immunol Immunother 59 629 633 20020123 10.1007/s00262-009-0805-5 [PubMed: 20020123]
27. S Shafiani G Tucker-Heard A Kariyone K Takatsu KB Urdahl 2010 Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis J Exp Med 207 1409 1420 20547826 10.1084/jem.20091885 1:CAS:528:DC%2BC3cXovFaktLs%3D [PubMed: 20547826]
28. T Stanislawski RH Voss C Lotz E Sadovnikova RA Willemsen J Kuball T Ruppert RL Bolhuis CJ Melief C Huber, et al. 2001 Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer Nat Immunol 2 962 970 11577350 10.1038/ni1001-962 1:CAS:528:DC%2BD3MXnsVCis70%3D [PubMed: 11577350] (Pubitemid 32976170)
29. SL Zhang JW Zhao ZQ Sun EZ Yang JH Yan Q Zhao GL Zhang HM Zhang YM Qi HH Wang, et al. 2009 Development and evaluation of a novel multiple-antigen ELISA for serodiagnosis of tuberculosis Tuberc Edinb 89 278 284 10.1016/j.tube.2009. 05.005 1:CAS:528:DC%2BD1MXht1ans73K [PubMed: 19559650]
30. X Zhu N Venkataprasad HS Thangaraj M Hill M Singh J Ivanyi HM Vordermeier 1997 Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection J Immunol 158 5921 5926 9190945 1:CAS:528:DyaK2sXktVWitLk%3D [PubMed: 9190945] (Pubitemid 127484000)
31. A Jorritsma TN Schumacher JB Haanen 2009 Immunotherapeutic strategies: the melanoma example Immunotherapy 1 679 690 20635992 1:CAS:528: DC%2BD1MXhtVygsrzJ [PubMed: 20635992]
32. Currier JR, Robinson MA (2001) Spectratype/immunoscope analysis of the expressed TCR repertoire. Curr Protoc Immunol Chapter 10: Unit 10.28 [PubMed: 18432693]
33. JC Sun MJ Bevan 2003 Defective CD8 T cell memory following acute infection without CD4 T cell help Science 300 339 342 12690202 10.1126/science.1083317 1:CAS:528:DC%2BD3sXislyqtb4%3D [PubMed: 12690202] (Pubitemid 36433727)